Resolute Wealth Advisor’s Candel Therapeutics CADL Stock Holding History
Bought
Maintained
Sold
Other funds holding CADL
ACA
SVCM
Resolute Wealth Advisor's CADL Position: Q3 2026 in Review
Resolute Wealth Advisor opened a new position in Candel Therapeutics (CADL) in Q3 2026: 350 shares worth $2.93K. The stake represents ﹤0.01% of the portfolio and ranks #346 among its holdings.
141 funds tracked by Wall St. Rank hold CADL as of Q3 2026.
- Resolute Wealth Advisor held 350 shares of Candel Therapeutics worth $2.93K as of Q3 2026.
- Candel Therapeutics was a new Resolute Wealth Advisor position in Q3 2026.
- Candel Therapeutics made up ﹤0.01% of Resolute Wealth Advisor's portfolio in Q3 2026, its #346 holding.
- 141 funds tracked by Wall St. Rank held Candel Therapeutics as of Q3 2026.
Based on Resolute Wealth Advisor's 13F filing for Q3 2026, filed 12 Nov 2026.